Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Shares Issued (2016 - 2025)

Lisata Therapeutics' Shares Issued history spans 13 years, with the latest figure at $1.1 million for Q4 2025.

  • For Q4 2025, Shares Issued rose 279.43% year-over-year to $1.1 million; the TTM value through Dec 2025 reached $1.7 million, up 210.5%, while the annual FY2025 figure was $844000.0, 1141.18% up from the prior year.
  • Shares Issued reached $1.1 million in Q4 2025 per LSTA's latest filing, up from $881510.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $1.1 million in Q4 2025 to a low of -$703000.0 in Q2 2023.
  • Average Shares Issued over 3 years is $229021.4, with a median of $270774.0 recorded in 2023.
  • Peak YoY movement for Shares Issued: changed 0.0% in 2024, then soared 279.43% in 2025.
  • A 3-year view of Shares Issued shows it stood at $270774.0 in 2023, then increased by 3.72% to $280848.0 in 2024, then skyrocketed by 279.43% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for LSTA's Shares Issued are $1.1 million (Q4 2025), $881510.0 (Q3 2025), and -$242343.0 (Q2 2025).